SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001415889-16-005699
Filing Date
2016-04-29
Accepted
2016-04-29 16:15:54
Documents
6
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A cocp10ka_dec312015.htm 10-K/A 530646
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER (302) ex31-1.htm EX-31.1 12226
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER (302) ex31-2.htm EX-31.2 14216
4 GARY WILCOX ADVISORY AGREEMENT ex10-16.htm EX-10.16 15069
5 JERRY MCGUIRE STOCK OPTION AGREEMENT ex10-17.htm EX-10.17 33079
6 CODE OF ETHICS ex14-1.htm EX-14.1 121705
  Complete submission text file 0001415889-16-005699.txt   728128
Mailing Address 1860 MONTREAL ROAD TUCKER GA 30084
Business Address 1860 MONTREAL ROAD TUCKER GA 30084 (425) 398-7178
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-55158 | Film No.: 161606769
SIC: 2834 Pharmaceutical Preparations